2 trials evaluate risk of lowering oxygen saturation targets

05/6/2013 | MedPage Today (free registration)

Two studies presented at a pediatric conference reached differing conclusions about the mortality and disability risks of lowering standard oxygen saturation targets for preterm infants. The Canadian Oxygen Trial published in the Journal of the American Medical Association found no significant effect, but the BOOST II study in the New England Journal of Medicine found a higher death rate.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD